Image Source: Equity Bulls
Commercial Syn Bags Ltd has announced a revision in the terms of its acquisition agreement with Erawat Pharma, executing an addendum to the Share Purchase Agreement (SPA) to reflect the updated deal structure and consideration.
Key Highlights:
-
The total consideration for the acquisition has been revised to ₹55.1 million, reflecting an increase in the transaction value.
-
The per-share consideration price for acquiring Erawat Vegcap, a wholly owned subsidiary of Erawat Pharma, has been revised upward to ₹58 per share.
-
This revision comes through an official addendum to the original SPA, ensuring all parties are aligned on the new terms.
-
The deal involves the acquisition of 950,000 equity shares of Erawat Vegcap, which operates in the plastic products, packaging, pharmaceutical, and healthcare sectors.
Erawat Vegcap, though incorporated in April 2022, has not commenced business operations, making this a strategic move for Commercial Syn Bags to expand its footprint and diversify its business interests.
The acquisition is expected to be completed by May 15, 2025, after which Erawat Vegcap will become a wholly owned subsidiary of Comsyn India, with Commercial Syn Bags as the ultimate holding company.
The transaction is not classified as a related party deal, and none of the promoters or group companies of Commercial Syn Bags have any direct or indirect interest in Erawat Vegcap.
This strategic acquisition is aimed at business expansion, diversification, and value creation for shareholders, further strengthening Commercial Syn Bags’ presence in both packaging and healthcare sectors.
Source: Business Standard
Advertisement
Advertisement